Tracker methods and sources

Study selection

Published trials cover DarDoc’s medicines and selected global programmes. Brand names help identify the active ingredients in the studies. Trial doses and formulations may differ from marketed products, and regulatory indications vary by country. Trial details link to the original paper, PubMed abstract and ClinicalTrials.gov record.

How to read results

Weight change is generally measured from randomisation. Withdrawal studies may start after a treatment lead-in. Treatment-policy and treatment-regimen analyses generally account for participants who stop treatment. The exact definition varies by study. Efficacy analyses may estimate what would happen if participants stayed on treatment. Results from separate trials describe their own populations and cannot establish which treatment works better.

Responder rates use the threshold named in each study. Safety percentages describe the specific event shown. A blank metric means the figure is absent from this dataset.

Regulatory milestones

UAE status comes from the Emirates Drug Establishment, Dubai Health Authority and UAE prescribing information. U.S. status comes from FDA records. Global entries use regulator decisions, trial registry records or dated sponsor reports. Sponsor filings and estimated trial dates are labeled separately. A registry completion date describes data collection and may precede results.

This tracker is for education. A physician can help interpret the evidence for your care.